Green Thumb Industries (GTBIF) Inventory Average (2020 - 2026)
Green Thumb Industries' (GTBIF) quarterly Inventory Average came in at $164.2 million in Q1 2026, up 8.54% YoY from $151.2 million in Q1 2025, and up 4.29% on a QoQ basis from $157.4 million in Q4 2025.
Green Thumb Industries (GTBIF) Inventory Average (2020 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 7 years of Inventory Average data on file, last reported at $164.2 million in Q1 2026.
- Quarterly Inventory Average rose 8.54% year-over-year to $164.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $164.2 million (up 8.54% YoY) and the FY2025 annual result came in at $152.7 million, up 17.42% from the prior year.
- Inventory Average climbed to $164.2 million in Q1 2026, from $157.4 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $164.2 million in Q1 2026 to a low of $102.6 million in Q1 2022.
- A 5-year average of $131.6 million and a median of $122.9 million in 2023 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 51.26% — and 2023, when it retreated 2.56%.
- Tracing GTBIF's Inventory Average over 5 years: stood at $118.8 million in 2022, then fell by 2.56% to $115.8 million in 2023, then rose by 23.29% to $142.7 million in 2024, then gained by 10.29% to $157.4 million in 2025, then rose by 4.29% to $164.2 million in 2026.
- The last three Inventory Average figures came in at $164.2 million (Q1 2026), $157.4 million (Q4 2025), and $154.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 824.00 Mn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 175.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 175.51 Mn |
| Mar 31, 2026 | 164.16 Mn |
| Dec 31, 2025 | 157.41 Mn |
| Sep 30, 2025 | 154.13 Mn |
| Jun 30, 2025 | 153.54 Mn |
| Mar 31, 2025 | 151.25 Mn |
| Dec 31, 2024 | 142.72 Mn |
| Sep 30, 2024 | 134.41 Mn |
| Jun 30, 2024 | 124.91 Mn |
| Mar 31, 2024 | 116.13 Mn |
| Dec 31, 2023 | 115.76 Mn |
| Sep 30, 2023 | 121.66 Mn |
| Jun 30, 2023 | 122.92 Mn |
| Mar 31, 2023 | 118.37 Mn |
| Dec 31, 2022 | 118.80 Mn |
| Sep 30, 2022 | 122.58 Mn |
| Jun 30, 2022 | 116.47 Mn |
| Mar 31, 2022 | 102.59 Mn |
| Dec 31, 2021 | 94.23 Mn |
| Sep 30, 2021 | 87.35 Mn |